German chemical giant Bayer AG applied for a patent in Japan on June 15, 2007, for a technique to generate induced pluripotent stem cells, or iPS cells, from human cells, according to Patent Office data.
The application was submitted around three months before a team led by Kyoto University professor Shinya Yamanaka announced the successful generation of iPS cells from human cells.
Unable to view this article?
This could be due to a conflict with your ad-blocking or security software.
Please add japantimes.co.jp and piano.io to your list of allowed sites.
If this does not resolve the issue or you are unable to add the domains to your allowlist, please see this support page.
We humbly apologize for the inconvenience.
In a time of both misinformation and too much information, quality journalism is more crucial than ever.
By subscribing, you can help us get the story right.
SUBSCRIBE NOW
With your current subscription plan you can comment on stories. However, before writing your first comment, please create a display name in the Profile section of your subscriber account page.